ArticleVeterinary research2025
Post-outbreak dynamics and persistence of Actinobacillus pleuropneumoniae serotype 15 in finisher pigs in Iowa.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Actinobacillus pleuropneumoniae - today's perspective on advances and challenges (2017- 2026).BMC veterinary research · 2026Review
- WH01-3A: a DIVA-compliant, ApxIA, ApxIIA, and ApxIIIA expressing Actinobacillus pleuropneumoniae live attenuated vaccine strain that protects mice and pigs against homologous and heterologous serovars.Veterinary research · 2026Article
- Transcriptomic and proteomic profiling ofFrontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In 2021, Actinobacillus pleuropneumoniae serotype 15 (App15) mediated a high mortality respiratory outbreak in finisher hogs, affecting multiple companies within a 30-km radius of Iowa, USA. The atypical regional spread raised concerns for the strain's unusual environmental persistence and survivability. This prospective longitudinal study aimed to determine the duration of App15 persistence in convalescent pigs at a naturally infected 1200 head site. Sixty-seven pigs were sampled individually for 6 weeks using nasal swabs (NS), tonsil scrapings (TS), and serum samples (SS); pen-based oral fluids (OF) were also collected. NS, TS, and OF were tested for App by rtPCR, while serum was screened with the Swinecheck mix-App ELISA. All 67 pigs tested App PCR positive in TS ≥ 1 during the sampling period, with progressive increases in detection from 53.3% to 95.8% between the first and last sampling week, respectively. Only 23 pigs (34.3%) were PCR positive by NS ≥ 1 during the sampling period, with decaying detection rates from a peak of 51.2% positivity in the first sampling week. Fifty-three of 73 pens (72.6%) tested App PCR positive in OF ≥ 1 during the sampling period. Seropositivity decreased from 93% on week 4- to 33% on week 8. TS had the highest PCR detection rate at all time points evaluated, representing the best antemortem sample type for App PCR detection in this study. The results reported here generated new important knowledge related to App15 ecology and epidemiology, prospectively informing disease diagnosis, surveillance, and biosecurity practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.